Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 37 (6) , 109988
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (16H06277, 18K19282, 20K16146)
- National Institutes of Health
- American Cancer Society
- National Cancer Institute (P01 CA120964, CA177910, R35CA197459, R35CA253027)
- Takeda Science Foundation
This publication has 62 references indexed in Scilit:
- mTOR Drives Its Own Activation via SCFβTrCP-Dependent Degradation of the mTOR Inhibitor DEPTORMolecular Cell, 2011
- Regulation of NF-κB activity by competition between RelA acetylation and ubiquitinationOncogene, 2011
- Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda -7/IL-24–mediated toxicityProceedings of the National Academy of Sciences, 2011
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destructionNature, 2011
- Transcriptional Synergy between Melanoma Antigen Gene Protein-A11 (MAGE-11) and p300 in Androgen Receptor SignalingJournal of Biological Chemistry, 2010
- Phosphorylation of Mcl‐1 by CDK1–cyclin B1 initiates its Cdc20‐dependent destruction during mitotic arrestThe EMBO Journal, 2010
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule InhibitorChemistry & Biology, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- mTORC1 promotes survival through translational control of Mcl-1Proceedings of the National Academy of Sciences, 2008